TP53 and intrahepatic cholangiocarcinoma: Our results demonstrate that targeting Trp53, Fbxw7, Inppl1, Tgfbr2, and Cul3 in hepatocytes using CRISPR/Cas9 generated ICC tumors in SPC mice, indicating five novel tumor suppressor genes for ICC.